Minerva Neurosciences NERV Institutional Ownership

Updated Oct 11, 2026

Minerva Neurosciences, Inc. (NASDAQ:NERV) counted 61 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• These investors held 89.61% of Minerva Neurosciences' outstanding shares at the end of Q2 2026, up from 87.24% in Q1 2026.
• Total holdings of NERV shares rose 10.50% from Q1 2026, and the holder count rose 205.00% from Q2 2025.
• Of the 61 holders of NERV in Q2 2026, 39 added to their positions, 9 reduced their stakes and 13 left their positions unchanged.
• Combined, institutional investors held 42.32Mn shares of NERV as of Q2 2026, up 4.02Mn from the prior quarter and up 40.39Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Minerva Neurosciences was Federated Hermes, Inc. with 4.67Mn shares, or 9.89% of shares outstanding.
• The biggest increases in NERV positions during Q2 2026 came from BlackRock, Inc. (+1.62Mn shares), Seven Fleet Capital Management LP (+752.9K shares), Geode Capital Management, LLC (+635.5K shares), Ally Bridge Group (NY) LLC (+520.3K shares) and State Street Corp (+368.57K shares).
• The biggest cuts to NERV positions during Q2 2026 came from Federated Hermes, Inc. (-442.8K shares), Millennium Management LLC (-174.69K shares), UBS Group AG (-25.36K shares), Renaissance Technologies LLC (-16.4K shares) and Morgan Stanley (-11.89K shares).
• Minerva Neurosciences' 10 largest institutional shareholders as of Q2 2026 were Federated Hermes, Inc. (4.67Mn shares), Jupiter Topco LLC (4.39Mn shares), Vivo Capital, LLC (4.32Mn shares), Balyasny Asset Management L.P. (4.26Mn shares), Logos Global Management LP (3.29Mn shares), Farallon Capital Management, L.L.C. (2.37Mn shares), BlackRock, Inc. (2.24Mn shares), Ally Bridge Group (NY) LLC (2.18Mn shares), Foresite Capital Management VI LLC (1.99Mn shares) and Vanguard Capital Management LLC (1.89Mn shares), per Business Quant data.